Related Experiment Video
Updated: Aug 7, 2026
04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
Hepatic epithelioid hemangioendothelioma
K Uchimura1, M Nakamuta, M Osoegawa
1Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Journal of Clinical Gastroenterology
|April 25, 2001
Summary
Epithelioid hemangioendothelioma (EHE) is a rare liver tumor. This study found similar clinical features and treatment outcomes in Japanese and Western patients, with no significant gender incidence difference.
Area of Science:
- Oncology
- Vascular Neoplasms
Background:
- Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with variable malignant potential.
- Primary hepatic EHE presents diagnostic and therapeutic challenges due to its rarity and unpredictable behavior.
Observation:
- This study reviewed two primary hepatic EHE cases in Japan and 34 previously reported cases.
- Clinical presentation, treatment outcomes, and tumor progression in Japanese patients mirrored those in Western populations.
- A notable finding was the absence of a significant gender-based incidence difference in Japanese EHE patients, contrary to some previous reports.
Findings:
- Hepatic EHE typically exhibits a low-grade malignant, slow-progressing phenotype.
- The tumor demonstrates resistance to chemotherapy, necessitating alternative treatment strategies.
- Positive staining for factor VIII-related antigen is a key diagnostic histologic marker.
Implications:
- Rapid diagnosis via imaging and histology is crucial for effective management.
- Surgical resection or liver transplantation are the recommended primary treatment modalities for hepatic EHE.
- Further research into EHE's pathogenesis and novel therapeutic targets is warranted given its resistance to conventional treatments.
